加载中
AMEXHealthcareMedical - Instruments & Supplies
最新数据
US$1.14
+US$0.03 · +2.70%
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
前收盘价
US$1.14
+US$0.03 · +2.70%
盘后
US$1.16
+US$0.02 · +1.75%
10月12日 19:49 ET
盘中时间采用ET。市场数据可能有所延迟。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日内区间
当前US$1.14
52周区间
当前US$1.14
盘中时间采用ET。市场数据可能有所延迟。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日内区间
当前US$1.14
52周区间
当前US$1.14
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3237.7万 USD | 2691.8万 USD | 2677.1万 USD | 2814.7万 USD | 3502.1万 USD |
| 销货成本 | 1530.6万 USD | 1232.4万 USD | 1191.1万 USD | 967.7万 USD | 1178.9万 USD |
| 毛利 | 1707.1万 USD | 1459.4万 USD | 1486万 USD | 1847万 USD | 2323.2万 USD |
| 研究与开发 | 938.3万 USD | 976万 USD | 1027.3万 USD | 1055.8万 USD | 1019.9万 USD |
| 销售、一般及管理费用 | 3029.2万 USD | 2957.3万 USD | 2642.6万 USD | 2668.8万 USD | 2592.1万 USD |
| 营业费用 | 3918.3万 USD | 3933.3万 USD | 3669.9万 USD | 3724.6万 USD | 3612万 USD |
| 利息收入 | 46.7万 USD | 69.4万 USD | 109.6万 USD | 48.4万 USD | — |
| 利息支出 | — | — | — | — | 1.01万 USD |
| 折旧和摊销 | 155.5万 USD | 96.9万 USD | 59.5万 USD | 42.9万 USD | 10.6万 USD |
| 营业利润 | −2211.2万 USD | −2473.9万 USD | −2183.9万 USD | −1877.6万 USD | −1288.8万 USD |
| 净利润 | −2164.3万 USD | −2404.5万 USD | −2071.3万 USD | −1829.2万 USD | −1071.6万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
